Search Results
GPR120 Agonist 2 2 mg | Purity Not Available
TargetMol
ALW-II-41-27 1 mg | 99.52%
TargetMol

ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
More Information Supplier PageALW-II-41-27 2 mg | 99.52%
TargetMol

ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
More Information Supplier PageSCH-23390 hydrochloride 5 mg | 99.07%
TargetMol

SCH 23390 hydrochloride is an effective dopamine receptor antagonist, and for the D1(Ki=0.2 nM) and D5(Ki=0.3 nM).
More Information Supplier PageSCH-23390 hydrochloride 2 mg | 99.07%
TargetMol

SCH 23390 hydrochloride is an effective dopamine receptor antagonist, and for the D1(Ki=0.2 nM) and D5(Ki=0.3 nM).
More Information Supplier PageSB756050 25 mg | 98.35%
TargetMol
ALW-II-41-27 50 mg | 99.52%
TargetMol

ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
More Information Supplier PageALW-II-41-27 25 mg | 99.52%
TargetMol

ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
More Information Supplier PageALW-II-41-27 10 mg | 99.52%
TargetMol

ALW-II-41-27, an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
More Information Supplier Page